Coronary Circulation Clinical Trial
Official title:
Effects of Suggestive Components of Therapeutical Interventions on the Diameter of Coronary Arteries
The aim of this randomized controlled pilot study was to answer the following questions:
1. Is it possible to affect the diameter of coronary arteries through a placebo injection,
which is administered intracoronarily together with a standardized verbal suggestion of
coronary vasodilation?
2. Is it possible to affect the diameter of coronary arteries through a pharmacologically
underdosed nitroglycerine injection, which is administered intracoronarily together
with a standardized verbal suggestion of coronary vasodilation?
The present study is a randomized controlled double-blind single center study in order to
investigate the effects of verbal suggestions ('vasodilatation') in combination with either
a placebo-intervention (sodium chloride 0.9%) or an underdosed vasodilating medication
(nitroglycerine) on the diameter of coronary arteries. 60 patients with a clinical
indication to undergo a coronary angiogram were recruited in the German Heart Centre Munich.
Patients with acute myocardial events and the necessity for coronary intervention were
excluded from the study. Patients were randomized into one of four arms of the two
experiments:
Experiment A: Intracoronary (i.c.) placebo-infusion together with a standardized verbal
suggestion of coronary vasodilation vs. i.c. placebo-infusion without verbal suggestion.
Experiment B: i.c. infusion of a very low dosed nitroglycerin together with a standardized
verbal suggestion of coronary vasodilation vs. i.c. nitroglycerine infusion without verbal
suggestion.
To our best knowledge this study is the first to investigate the modulating effects of
verbal suggestions going along with medical interventions on the diameter of coronary
arteries during heart catheterization.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03193294 -
CORonary MICrovascular Angina (CorMicA)
|
N/A | |
Recruiting |
NCT03033810 -
FFR Versus iFR in Assessment of Hemodynamic Lesion Significance
|
N/A | |
Recruiting |
NCT04575207 -
The Flash FFR Ⅱ Study
|
N/A | |
Active, not recruiting |
NCT03656848 -
The FAVOR III China Study
|
N/A | |
Completed |
NCT03067844 -
Vascular Effects of Alirocumab in Acute MI-Patients
|
Phase 3 |